Julio Gonzalez Moraleja
Overview
Explore the profile of Julio Gonzalez Moraleja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Cervera C, Giner-Galvan V, Wikman-Jorgensen P, Laureiro J, Rubio-Rivas M, Gurjian Arena A, et al.
J Gen Intern Med
. 2021 Jul;
36(11):3478-3486.
PMID: 34287774
Background: Venous thrombotic events (VTE) are frequent in COVID-19, and elevated plasma D-dimer (pDd) and dyspnea are common in both entities. Objective: To determine the admission pDd cut-off value associated...
2.
Calderon-Parra J, Muino-Miguez A, Bendala-Estrada A, Ramos-Martinez A, Munez-Rubio E, Fernandez Carracedo E, et al.
PLoS One
. 2021 May;
16(5):e0251340.
PMID: 33974637
Background: Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections are rare. This can lead to increased complications, including antibacterial resistance. We aim to analyze risk factors...
3.
Del Mar Ayala Gutierrez M, Rubio-Rivas M, Romero Gomez C, Montero Saez A, Perez de Pedro I, Homs N, et al.
J Clin Med
. 2021 Apr;
10(9).
PMID: 33922777
(1) Objectives: To describe the clinical characteristics and clinical course of hospitalized patients with COVID-19 and autoimmune diseases (ADs) compared to the general population. (2) Methods: We used information available...
4.
Torres-Pena J, Perez-Belmonte L, Fuentes-Jimenez F, Lopez Carmona M, Perez-Martinez P, Lopez-Miranda J, et al.
Drugs
. 2021 Mar;
81(6):685-695.
PMID: 33782908
Background: The impact of statins on COVID-19 outcomes is important given the high prevalence of their use among individuals at risk for severe COVID-19. Our aim is to assess whether...
5.
Artero A, Madrazo M, Fernandez-Garces M, Muino Miguez A, Garcia A, Crestelo Vieitez A, et al.
J Gen Intern Med
. 2021 Feb;
36(5):1338-1345.
PMID: 33575909
Background: Identification of patients on admission to hospital with coronavirus infectious disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been comprehensively assessed. Objective: To compare severity...
6.
Rodilla E, Lopez-Carmona M, Cortes X, Cobos-Palacios L, Canales S, Saez M, et al.
Hypertension
. 2020 Dec;
77(3):856-867.
PMID: 33377393
Older age and cardiovascular comorbidities are well-known risk factors for all-cause mortality in patients with coronavirus disease 2019 (COVID-19). Hypertension and age are the 2 principal determinants of arterial stiffness...